Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...

This retrospective cohort study was designed to provide further information on the association between BP parameters and VF ...

The designations underscore the unmet need in Stargardt disease, a rare and serious pediatric disease for which no treatment ...

The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar referencing Eylea (aflibercept). The biosimilar has been developed and registered by ...